79
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Influence of Captopril on Red Cell Velocity in the Vasa Recta of the Renal Medulla

Pages 149-158 | Published online: 18 Jan 2010
 

Abstract

Previous studies from our laboratory have indicated an important role for angiotensin II (All) in the regulation of renal medullary haemodynamics during normal physiological conditions. In order to investigate further the influence of endogenous All on the juxtamedullary vascular resistance in anaesthetized rats the velocity of fluorescently-labeled red cells (vRBC) was measured with a cross-correlation technique in the vasa recta before and after infusion of the angiotensin I- converting enzyme inhibitor captopril or vehicle.

Irrespective of treatment, vRBC was higher in the descending vasa recta (DVR) than in the ascending vasa recta (AVR). In time control animals vRBC in DVR and AVR and mean arterial blood pressure (MAP) remained stable over the 45 min study period. In animals receiving captopril (3 mg·h−1·kg−1 bw) vRBC increased almost proportionally in DVR and AVR; by 26% in DVR (from 1.02 ± 0.12 to 1.28 ± 0.10 mm·s−1, p < 0.05) and by 19% in AVR (from 0.46 ± 0.05 to 0.55 ± 0.07 mm·s−1, p<0.05). MAP decreased by 9% (from 107 ± 3 to 97 ± 2 mm Hg, p<0.05).

These results give further support to the suggestion of an involvement of All in the regulation of juxtamedullary vascular resistance during normal physiological conditions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.